Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew D. La Fontaine
Matthew D. La Fontaine
Netherlands Cancer Institute
Radiology
Medicine
Primary tumor
Positron emission tomography
Lung cancer
4
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The dynamics and prognostic value of FDG PET-metrics in weekly monitoring of (chemo)radiotherapy for NSCLC.
2021
Radiotherapy and Oncology
Matthew D. La Fontaine
N.M. Bruin
Simon van Kranen
J. Knegjens
Jeroen B. van de Kamer
Wouter V. Vogel
Jan-Jakob Sonke
Show All
Source
Cite
Save
Citations (1)
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
2020
PLOS ONE
T. Konert
Sarah Everitt
Matthew D. La Fontaine
Jeroen B. van de Kamer
Michael MacManus
Wouter V. Vogel
Jason Callahan
Jan-Jakob Sonke
Show All
Source
Cite
Save
Citations (13)
Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC
2019
Radiotherapy and Oncology
Judi van Diessen
Matthew D. La Fontaine
Michel M. van den Heuvel
Erik van Werkhoven
Iris Walraven
Wouter V. Vogel
José Belderbos
Jan-Jakob Sonke
Show All
Source
Cite
Save
Citations (2)
Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume.
2018
International Journal of Radiation Oncology Biology Physics
Gilles Defraene
Matthew D. La Fontaine
Simon van Kranen
Bart Reymen
José Belderbos
Jan-Jakob Sonke
Dirk De Ruysscher
Show All
Source
Cite
Save
Citations (3)
1